Dutasteride Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Dutasteride market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.

    This report presents the market size and development trends by detailing the Dutasteride market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dutasteride market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dutasteride industry and will help you to build a panoramic view of the industrial development.

    Dutasteride Market, By Type:

    • Avodart

    • Generic Avodart

    Dutasteride Market, By Application:

    • Hospital

    • Drug store

    Some of the leading players are as follows:

    • GSK

    • Zydus

    • Mylan

    • Breckenridge Pharmaceutical

    • Amneal Pharma

    • Marksans Pharma

    • Rising Pharmaceuticals

    • Teva

    • Bionpharma

    • Apotex

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Dutasteride Market: Technology Type Analysis

    • 4.1 Dutasteride Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Dutasteride Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Avodart

      • 4.3.2 Generic Avodart

    5 Dutasteride Market: Product Analysis

    • 5.1 Dutasteride Product Market Share Analysis, 2018 & 2026

    • 5.2 Dutasteride Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Dutasteride Market: Application Analysis

    • 6.1 Dutasteride Application Market Share Analysis, 2018 & 2026

    • 6.2 Dutasteride Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Drug store

    7 Dutasteride Market: Regional Analysis

    • 7.1 Dutasteride Regional Market Share Analysis, 2018 & 2026

    • 7.2 Dutasteride Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GSK

      • 9.1.1 GSK Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Zydus

      • 9.2.1 Zydus Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Mylan

      • 9.3.1 Mylan Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Breckenridge Pharmaceutical

      • 9.4.1 Breckenridge Pharmaceutical Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Amneal Pharma

      • 9.5.1 Amneal Pharma Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Marksans Pharma

      • 9.6.1 Marksans Pharma Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Rising Pharmaceuticals

      • 9.7.1 Rising Pharmaceuticals Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Teva

      • 9.8.1 Teva Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Bionpharma

      • 9.9.1 Bionpharma Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Apotex

      • 9.10.1 Apotex Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 67 Figures and 123 Tables)

    • Figure Avodart Dutasteride market, 2015 - 2026 (USD Million)

    • Figure Generic Avodart Dutasteride market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Drug store market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Dutasteride market, by country, 2015 - 2026 (USD Million)

    • Table North America Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table North America Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table North America Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Canada Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Canada Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Europe Dutasteride market, by country, 2015 - 2026 (USD Million)

    • Table Europe Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Europe Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Europe Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Germany Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Germany Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table France Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table France Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Italy Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Italy Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Spain Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Spain Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dutasteride market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table China Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table China Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Japan Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Japan Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table India Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table India Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Dutasteride market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table MEA Dutasteride market, by country, 2015 - 2026 (USD Million)

    • Table MEA Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table MEA Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table MEA Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Dutasteride market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Dutasteride market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Dutasteride market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Zydus Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Breckenridge Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amneal Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Marksans Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Rising Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teva Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bionpharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Apotex Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.